What Is Semax? The Nootropic and Neuroprotection Research Peptide Explained

Semax ACTH 4-10 analog nootropic neuroprotection BDNF research peptide Durham Peptides Canada

Most of the attention in research peptides goes to metabolic and tissue-repair compounds — but there's a distinct and rapidly growing category that gets far less coverage: nootropic and neuroprotective research peptides. Semax sits at the center of it. As a synthetic analog of a fragment of adrenocorticotropic hormone (ACTH), modified for stability, Semax has been studied for decades in neuroscience research — including effects on BDNF signaling, neuroprotection in ischemia models, and cognitive pathways. For Canadian researchers exploring the neuropeptide space, it's one of the most well-characterized compounds available.

This article explains what Semax is, its origin and structure, the neuroscience it's studied for, and where it fits in the research peptide landscape. For Canadian researchers, Durham Peptides supplies Semax 10mg. Nothing here is medical, dosing, or therapeutic guidance.

The Origin: A Stabilized ACTH Fragment

Semax is a synthetic heptapeptide analog of the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. The native ACTH(4-10) fragment has neuroactive properties but is rapidly degraded; Semax's design adds a C-terminal Pro-Gly-Pro tripeptide extension that substantially improves metabolic stability and bioavailability, allowing the molecule to persist long enough to be studied as a research tool.

Semax has been the subject of extensive research in Russia, where it appears on the country's List of Vital & Essential Drugs and has been studied in clinical settings for cerebrovascular and cognitive research. That clinical-research history — uncommon among research peptides — gives Semax an unusually deep literature base.

The Molecular Basics

Durham Peptides' Semax is a well-characterized heptapeptide:

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro (seven amino acids)

• Molecular formula: C₃₇H₅₁N₉O₁₀S

• Molecular weight: 813.92 g/mol

• CAS number: 80714-61-0

• Common synonyms: ACTH(4-7)-PGP, Semax Peptide

The compact heptapeptide structure is part of what makes Semax research-relevant: its small size is studied in the context of blood-brain-barrier penetration and central-nervous-system access.

The Core Mechanism: BDNF and Neurotrophic Signaling

The most studied aspect of Semax is its investigated effect on BDNF (brain-derived neurotrophic factor) — a key signaling protein involved in neuron survival, growth, and synaptic plasticity. Semax has been studied for modulating BDNF expression and its receptor TrkB in hippocampal and cortical tissue models. Because BDNF is central to learning, memory, and neuronal resilience, this BDNF-modulation pathway is the mechanistic anchor for much of the cognitive and neuroprotective research interest in Semax.

Neuroprotection in Ischemia Research

A second major research thread is neuroprotection. Semax has been studied in models of cerebral ischemia and stroke — particularly focal-ischemia (pMCAO) models — where research has examined its investigated effects on neuronal survival and on the gene-expression response of immune and vascular systems following ischemic events. The Russian clinical-research literature reflects this neuroprotection focus.

Cognitive and Neurotransmitter Research

Semax has also been explored for its investigated effects on:

• Learning, memory, and attention pathways (the "nootropic" research angle)

• Monoaminergic neurotransmitter metabolism — serotonin, dopamine, and norepinephrine systems

• Copper(II) chelation and amyloid-beta aggregation modulation, a thread relevant to neurodegeneration research

What Researchers Examine

• BDNF and TrkB expression in hippocampal and cortical tissue models

• Neuroprotective effects in focal-ischemia (pMCAO) models

• Monoaminergic neurotransmitter metabolism (serotonin, dopamine, norepinephrine)

• Gene-expression profiling of immune and vascular systems post-ischemia

• Copper(II) chelation and amyloid-beta aggregation modulation

Semax and the Broader Neuropeptide Category

Semax is frequently studied alongside Selank, another Russian-developed neuropeptide that Durham Peptides also carries (Selank 10mg). Where Semax research centers on BDNF, neuroprotection, and cognitive pathways, Selank research centers more on anxiolytic and immunomodulatory pathways. Together they represent the two anchor compounds of the nootropic / neuropeptide research category — a distinct vertical from the metabolic, recovery, and longevity categories.

For the foundational overview of how peptides like Semax fit the broader field, see What Are Peptides? A Beginner's Guide.

Quality and Storage

Durham Peptides' Semax is supplied as a 10mg lyophilized peptide, Janoshik-verified to ≥99% purity by HPLC with mass-spec identity confirmation and a verifiable COA key, 100% synthetically manufactured (vegan). Storage: 2–8°C short-term, -20°C long-term, protected from light and moisture; reconstitute in bacteriostatic water. See How to Read a Janoshik COA and the peptide calculator for reconstitution math.

Frequently Asked Questions

What is Semax? A synthetic heptapeptide analog of the ACTH(4-10) fragment (with a stabilizing Pro-Gly-Pro extension), studied for BDNF modulation, neuroprotection, and cognitive research.

What is Semax studied for? Primarily BDNF/neurotrophic signaling, neuroprotection in cerebral-ischemia models, and cognitive/attention pathways, plus neurotransmitter-metabolism research.

How does Semax differ from the original ACTH fragment? Semax adds a C-terminal Pro-Gly-Pro tripeptide that improves metabolic stability and bioavailability versus the rapidly degraded native ACTH(4-10) fragment.

Is Semax a nootropic? In research contexts, Semax is studied for nootropic-type effects (learning, memory, attention pathways), largely via its investigated BDNF modulation. It is sold for laboratory use only, not as a supplement or therapeutic.

What's the difference between Semax and Selank? Both are Russian-developed neuropeptides. Semax research centers on BDNF, neuroprotection, and cognition; Selank research centers more on anxiolytic and immunomodulatory pathways. Durham Peptides stocks both.

Where can I buy Semax in Canada? Durham Peptides supplies Semax 10mg for laboratory use only, Janoshik-verified and shipped same-day from Ontario.

Final Thoughts

Semax anchors a category of research peptides that's often overlooked next to the metabolic and recovery compounds: the nootropic and neuroprotective neuropeptides. Its stabilized ACTH-fragment design, decades of published neuroscience research, and well-characterized BDNF and neuroprotection pathways make it one of the most research-ready compounds in the neuropeptide space.

For Canadian researchers, Durham Peptides supplies Semax 10mg at C$45.00, with Selank available as its frequent research companion. For the foundational peptide overview, see What Are Peptides?. Browse the full catalog at durhampeptides.ca/category/all-products.

Selected Research References

1. Dergunova LV, Dmitrieva VG, Filippenkov IB, et al. The Peptide Drug Semax Suppresses mRNA Transcripts Encoding Proinflammatory Mediators in the Rat Brain Following Ischemia. Molecular Biology. 2014. https://pubmed.ncbi.nlm.nih.gov/24708833/

2. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an Analog of ACTH(4-10) with Cognitive Effects, Regulates BDNF and trkB Expression in the Rat Hippocampus. Brain Research. 2006. https://pubmed.ncbi.nlm.nih.gov/16996040/

3. Agapova TY, Agniullin YV, Silachev DN, et al. Effect of Semax on Brain-Derived Neurotrophic Factor and trkB Gene Expression in the Rat Hippocampus. Molecular Genetics, Microbiology and Virology. 2008. https://pubmed.ncbi.nlm.nih.gov/18652270/

All products sold by Durham Peptides are for research and laboratory use only. They are not intended for human or animal consumption, diagnosis, treatment, cure, or prevention of any disease.